Endomorphin-1 and -2 Cause Pain at High Doses Through Different Mechanisms in the Brain

High-dose endomorphin-1 and endomorphin-2 both caused anti-analgesia (pain) in the brainstem, but through different mechanisms — endomorphin-1 via direct NMDA activation, endomorphin-2 via dynorphin release — different peptides, different pronociceptive pathways.

Terashvili, Maia et al.·The Journal of pharmacology and experimental therapeutics·2005·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01090Animal StudyPreliminary Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

High-dose endomorphin-1 anti-analgesia in ventral PAG was mediated by direct NMDA receptor activation, while endomorphin-2 worked through dynorphin A release → kappa/NMDA pathways — two endogenous mu-agonists producing pain through distinct mechanisms.

Key Numbers

How They Did This

animal-study study on opioid-peptides, pain.

Why This Research Matters

Relevant for opioid-peptides, pain.

The Bigger Picture

Advances peptide/biomarker research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding High-dose endomorphin-1 anti-analgesia in ventral PAG was mediated by direct NMDA receptor activation, while endomorphin-2 worked through dynorphin A
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2005.
Original Title:
Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.
Published In:
The Journal of pharmacology and experimental therapeutics, 312(3), 1257-65 (2005)
Database ID:
RPEP-01090

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Endomorphin-1 and -2 Cause Pain at High Doses Through Different Mechanisms in the Brain

What was found?

High-dose endomorphin-1 and endomorphin-2 both caused anti-analgesia (pain) in the brainstem, but through different mechanisms — endomorphin-1 via direct NMDA activation, endomorphin-2 via dynorphin release — different peptides, different pronociceptive pathways.

Read More on RethinkPeptides

Cite This Study

RPEP-01090·https://rethinkpeptides.com/research/RPEP-01090

APA

Terashvili, Maia; Wu, Hsiang-En; Leitermann, Randy J; Sun, Han-Sen; Clithero, Andrew D; Tseng, Leon F. (2005). Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.. The Journal of pharmacology and experimental therapeutics, 312(3), 1257-65.

MLA

Terashvili, Maia, et al. "Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.." The Journal of pharmacology and experimental therapeutics, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Differential mechanisms of antianalgesia induced by endomorp..." RPEP-01090. Retrieved from https://rethinkpeptides.com/research/terashvili-2005-differential-mechanisms-of-antianalgesia

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.